Status:
UNKNOWN
Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia
Lead Sponsor:
Hospital Universitario Pedro Ernesto
Collaborating Sponsors:
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Conditions:
Hypertension
Hypertriglyceridemia
Eligibility:
All Genders
40-65 years
Phase:
PHASE4
Brief Summary
The objective of this study is to compare the effects of ciprofibrate versus omega-3 fatty acid supplementation on the vascular structure and function in hypertensive patients with hypertriglyceridemi...
Detailed Description
Hypertensive patients aged 40-65 years, both genders, presenting serum triglycerides levels higher than 150 mg/dl will be randomized into two groups. The first group will be receiving ciprofibrate 100...
Eligibility Criteria
Inclusion
- Previous diagnosis of hypertension
- Patients with serum triglycerides levels ≥ 150 mg/dl and \<500 mg/dl
- Patients on stable antihypertensive medication for at least 4 weeks
- Patients with food consumption maintained for at least 4 weeks
Exclusion
- Smoking
- Secondary hypertension
- Hormone replacement therapy
- Diabetes mellitus
- Chronic kidney disease
- Known coronary artery disease
- Previous stroke
- Dyslipidemia severe, with LDL cholesterol\> 160 mg/dL or triglycerides ≥ 500 mg/dl
- Use of statins or beta blockers
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01480687
Start Date
May 1 2011
End Date
December 1 2012
Last Update
November 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Pedro Ernesto
Rio de Janeiro, RJ, Rio de Janeiro, Brazil